MP0317 in Combination With Chemoimmunotherapy in First Line Treatment for Patients With Advanced Biliary Tract Carcinoma
Abroad (travel likely)RecruitingPHASE2
Conditions
Advanced Biliary Tract Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
CHU de Besançon, Besançon, France
Contact: Study coordinator (Christophe BORG, Pr)Centre georges-François Leclerc, Dijon, France
Contact: Study coordinator (François GHIRINGHELLI, Pr)CHU de Grenoble, Grenoble, France
Contact: Study coordinator (Gaël ROTH, Dr)Centre Léon Bérard, Lyon, France
Contact: Study coordinator (Philippe CASSIER, Dr)CHU de Montpellier, Montpellier, France
Contact: Study coordinator (Eric ASSENAT, Pr)Hôpital Beaujon, Paris, France
Contact: Study coordinator (Mohammed BOUATTOUR, Dr)Hôpital La Pitié-Salpétrière, Paris, France
Contact: Study coordinator (Jean-Baptiste BACHET, Pr)Institut Curie, Paris, France
Contact: Study coordinator (Cindy NEUZILLET, Pr)Centre Eugène Marquis, Rennes, France
Contact: Study coordinator (Julien EDELINE, Pr)CHU de Tours, Tours, France
Contact: Study coordinator (Romain CHAUTARD, Dr)Institut Gustave Roussy, Villejuif, France
Contact: Study coordinator (Antoine HOLLEBECQUE, Pr)
Study leads
Christophe BORG
Study Director
CHU Besançon